Sun Pharma launches drug to treat Plaque psoriasis in Canada
newsdepo.com
The company said ILUMYA (tildrakizumab injection) has already completed a five-year study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.Sun Pharma launches drug to treat Plaque psoriasis in Canada
The company said ILUMYA (tildrakizumab injection) has already completed a five-year study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis. Read more